Prophylaxis for Venous Thromboembolism: A Great Global Divide between Expert Guidelines and Clinical Practice?

Behnood Bikdeli; Babak Sharif-Kashani

doi:10.1055/s-0032-1301412

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2012; 38(02): 144-155
DOI: 10.1055/s-0032-1301412

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prophylaxis for Venous Thromboembolism: A Great Global Divide between Expert Guidelines and Clinical Practice?

Autoren

Behnood Bikdeli

¹Cardiovascular Department, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University MC, Tehran, Iran

²Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut

³Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut
Babak Sharif-Kashani

¹Cardiovascular Department, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University MC, Tehran, Iran

⁴Tobacco Prevention and Control Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University MC, Tehran, Iran

Abstract

Our understanding of development and prevention of venous thromboembolism (VTE) has improved dramatically since Virchow described the triad of stasis, hypercoagulability, and endothelial dysfunction during the mid-1800s. A full arsenal of effective pharmacological and mechanical methods can help prevent VTE and many professional organizations have provided extensive evidence-based statements for VTE prophylaxis. Disappointingly, however, VTE has remained the major preventable cause of hospital death. Adherence rate to clinical guidelines is undesirably low. Many real-world patients have also been excluded from VTE prevention trials and hence practice guidelines recommendations. The comprehensive and repetitious formats of many available guidelines also limit their readability and applicability by nonthrombosis specialists. Moreover, some patients suffer from VTE despite complying with the contemporary prophylaxis regimens. Besides, significant heterogeneity exists in thromboprophylaxis practice and pitfalls between different countries. Last but not the least; although many at-risk patients are underprophylaxed, there is evidence to suggest that overprophylaxis (i.e., prescription of thromboprophylaxis in low-risk patients) comprises another important problem. We review the thromboprophylaxis practice and pitfalls around the world and provide recommendations on how the major obstacles can be overcome.

Keywords

venous thromboembolism - prevention - prophylaxis - guidelines adherence

Volltext

Referenzen

References
1 RLK V. Thrombose und embolie. GefUssen entzLlndung und septische infektion. In: Virchow RLK, , ed. Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt: Barth; 1856: 219-732
2 Wells PS, Anderson DR, Bormanis J , et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet 1997; 350 (9094) 1795-1798
3 Wells PS, Anderson DR, Rodger M , et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83 (3) 416-420
4 Di Nisio M, Squizzato A, Rutjes AWS, Büller HR, Zwinderman AH, Bossuyt PMM. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost 2007; 5 (2) 296-304
5 Hamper UM, DeJong MR, Scoutt LM. Ultrasound evaluation of the lower extremity veins. Radiol Clin North Am 2007; 45 (3) 525-547, ix
6 Hayashino Y, Goto M, Noguchi Y, Fukui T. Ventilation-perfusion scanning and helical CT in suspected pulmonary embolism: meta-analysis of diagnostic performance. Radiology 2005; 234 (3) 740-748
7 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353 (9162) 1386-1389
8 Geerts WH, Pineo GF, Heit JA , et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3, Suppl) 338S-400S
9 Kahn SR. The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis. J Thromb Thrombolysis 2006; 21 (1) 41-48
10 Pini M, Spyropoulos AC. Prevention of venous thromboembolism. Semin Thromb Hemost 2006; 32 (8) 755-766
11 Tufano A, Coppola A, Cerbone AM, Ruosi C, Franchini M. Preventing postsurgical venous thromboembolism: pharmacological approaches. Semin Thromb Hemost 2011; 37 (3) 252-266
12 Lippi G, Favaloro EJ, Cervellin G. Prevention of venous thromboembolism: focus on mechanical prophylaxis. Semin Thromb Hemost 2011; 37 (3) 237-251
13 Geerts WH, Bergqvist D, Pineo GF , et al; American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 381S-453S
14 Kucher N, Koo S, Quiroz R , et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005; 352 (10) 969-977
15 Piazza G, Seddighzadeh A, Goldhaber SZ. Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest 2007; 132 (2) 554-561
16 Nicolaides AN, Fareed J, Kakkar AK , et al; Cardiovascular Disease Educational and Research Trust; Cyprus Cardiovascular Disease Educational and Research Trust; European Venous Forum; International Surgical Thrombosis Forum; International Union of Angiology; Union Internationale de Phlébologie. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006; 25 (2) 101-161
17 Institute for Clinical Systems Improvement (ICSI). Venous thromboembolism prophylaxis. Bloomington (MN): : Institute for Clinical Systems Improvement (ICSI); ; 2010. Aug:45
18 Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51 (2–3) 70-80
19 Scottish Intercollegiate Guidelines Network (SIGN). Prevention and management of venous thromboembolism. Edinburgh: : SIGN; ; 2010. . (SIGN publication no. 122). [Cited 10 Dec 2010]. Available at: http://www.sign.ac.uk
20 Lyman GH, Khorana AA, Falanga A , et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol 2007; 25 (34) 5490-5505
21 Wagman LD, Baird MF, Bennett CL , et al; National Comprehensive Cancer Network. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2008; 6 (8) 716-753
22 American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty Adopted by the American Academy of Orthopedic Surgeons Board of Directors May. 2007 . Available at: www.aaos.org/research/guidelines/VTE/VTE_full_guideline.pdf . Accessed Jan 2011
23 Stahl TJ, Gregorcyk SG, Hyman NH, Buie WD ; Standards Practice Task Force of The American Society of Colon and Rectal Surgeons. Practice parameters for the prevention of venous thrombosis. Dis Colon Rectum 2006; 49 (10) 1477-1483
24 ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007; 110 (2 Pt 1) 429-440
25 Bergqvist D. Group prophylaxis is the best strategy. Dis Mon 2010; 56 (10) 560-562
26 Caprini JA. Individual risk assessment is the best strategy for thromboembolic prophylaxis. Dis Mon 2010; 56 (10) 552-559
27 Spyropoulos AC, Mahan C. Venous thromboembolism prophylaxis in the medical patient: controversies and perspectives. Am J Med 2009; 122 (12) 1077-1084
28 Kakkar AK, Davidson BL, Haas SK ; Investigators Against Thromboembolism (INATE) Core Group. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost 2004; 2 (2) 221-227
29 Lachiewicz PF. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. Orthopedics 2009; 32 (12, Suppl) 74-78
30 Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?. Chest 2009; 135 (2) 513-520
31 Sharif-Kashani B, Bikdeli B, Moradi A , et al. Coexisting venous thromboembolism in patients with tuberculosis. Thromb Res 2010; 125 (5) 478-480
32 Spyropoulos AC, Mahan C. Venous thromboembolism prophylaxis in the medical patient: controversies and perspectives. Am J Med 2009; 122 (12) 1077-1084
33 Cohen AT, Tapson VF, Bergmann JF , et al; ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371 (9610) 387-394
34 Dentali F, Riva N, Gianni M , et al. Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events. Thromb Res 2008; 123 (1) 67-71
35 Anderson Jr FA, Goldhaber SZ, Tapson VF , et al; ENDORSE Investigators. Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. Am J Med 2010; 123 (12) 1099-1106, e8
36 Sharif-Kashani B, Raeissi S, Bikdeli B , et al. Sticker reminders improve thromboprophylaxis appropriateness in hospitalized patients. Thromb Res 2010; 126 (3) 211-216
37 Bikdeli B, Sharif-Kashani B, Raeissi S, Ehteshami-Afshar S, Behzadnia N, Masjedi MR. Chest physicians’ knowledge of appropriate thromboprophylaxis: insights from the PROMOTE study. Blood Coagul Fibrinolysis 2011; 22: 667-672
38 Sharif-Kashani B, Bikdeli B, Shahabi P , et al. AssessMent of ProphylAxis for VenouS ThromboembolIsm in Hospitalized Patients. The MASIH Study. Clin Appl Thromb Haemost, in press, DOI: 10.1177/1076029611431955
39 Tapson VF, Decousus H, Pini M , et al; IMPROVE Investigators. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007; 132 (3) 936-945
40 Friedman RJ, Gallus A, Gil-Garay E, FitzGerald G, Cushner F. Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty—insights from the Multinational Global Orthopaedic Registry (GLORY). Am J Orthop 2010; 39 (9, Suppl) 14-21
41 Kakkar AK, Levine M, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist 2003; 8 (4) 381-388
42 Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals’ compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm 2007; 64 (1) 69-76
43 Kahn SR, Panju A, Geerts W , et al; CURVE study investigators. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res 2007; 119 (2) 145-155
44 Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure?. J Thromb Haemost 2007; 5 (8) 1610-1616
45 Deheinzelin D, Braga AL, Martins LC , et al; Trombo Risc Investigators. Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil. J Thromb Haemost 2006; 4 (6) 1266-1270
46 Caiafa JS, de Bastos M, Moura LK, Raymundo S ; Brazilian Registry of venous thromboembolism prophylaxis. Managing venous thromboembolism in Latin American patients: emerging results from the Brazilian Registry. Semin Thromb Hemost 2002; 28 (Suppl 3) 47-50
47 Martínez-Zubieta R. [Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE II study): results of a Mexican national cross-sectional study]. Cir Cir 2010; 78 (4) 333-341
48 Akinmoladun VI, Arotiba JT, Fasola OA, Alonge TO, Oginni FO, Obuekwe ON. The use of thromboembolic prophylaxis by surgeons: a multicentre Nigerian study. Niger Postgrad Med J 2007; 14 (4) 330-335
49 Zotz RB, Kauschat-Brüning D, Bramlage P ; ENDORSE Studienleiter. [Thromboembolic risk and prophylaxis in hospitalized surgical and internal medicine patients. German results of the international ENDORSE study]. Dtsch Med Wochenschr 2009; 134 (43) 2163-2169
50 Rashid ST, Thursz MR, Razvi NA , et al. Venous thromboprophylaxis in UK medical inpatients. J R Soc Med 2005; 98 (11) 507-512
51 Gussoni G, Campanini M, Silingardi M , et al; GEMINI Study Group. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study. Thromb Haemost 2009; 101 (5) 893-901
52 Mokhtari M, Salameh P, Kouchek M, Kashani BS, Taher A, Waked M ; Avail Me Extension Study Group. The AVAIL ME Extension: a multinational Middle Eastern survey of venous thromboembolism risk and prophylaxis. J Thromb Haemost 2011; 9 (7) 1340-1349
53 Safavi E, Zahedpour Anaraki MR, Firooz Bakhsh S, Nikparvar Fard M. The study of diagnosed venous thromboembolism. Tanaffos 2003; 5: 15-22
54 Heidar Nezhad H, Zendeh Del N, Kolahi S, Pirzeh A, Eslam Panah S. Practice of deep vein thrombosis prophylaxis in teaching hospitals of Tabriz. Tanaffos 2003; 6: 31-37
55 Zeitoun AA, Dimassi HI, El Kary DY, Akel MG. An evaluation of practice pattern for venous thromboembolism prevention in Lebanese hospitals. J Thromb Thrombolysis 2009; 28 (2) 192-199
56 Sen RK, Tripathy SK, Singh AK. Is routine thromboprophylaxis justified among Indian patients sustaining major orthopedic trauma? A systematic review. Indian J Orthop 2011; 45 (3) 197-207
57 Zheng H, Liu L, Sun H , et al. Prophylaxis of deep venous thrombosis and adherence to guideline recommendations among inpatients with acute stroke: results from a multicenter observational longitudinal study in China. Neurol Res 2008; 30 (4) 370-376
58 Gibbs H, Fletcher J, Blombery P, Collins R, Wheatley D. Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit. Thromb J 2011; 9 (1) 7
59 National Institute of Clinical Studies. The prevalence of chemoprophylaxis in surgical and medical cases at high risk of venous thromboembolism. Prepared by The School of Population Health, University of Western Australia. NICS, Melbourne; 2005
60 Goldhaber SZ, Dunn K, MacDougall RC. New onset of venous thromboembolism among hospitalized patients at Brigham and Women’s Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest 2000; 118 (6) 1680-1684
61 Rajaganeshan R, Dussa CU, Sahni V. National survey in the United Kingdom of prophylaxis of deep vein thrombosis for patients with fracture of the neck of the femur. Injury 2006; 37 (8) 721-726
62 Seddighzadeh A, Zurawska U, Shetty R, Goldhaber SZ. Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion. Thromb Haemost 2007; 98 (6) 1220-1225
63 Cook D, Laporta D, Skrobik Y , et al; Canadian ICU Directors Group. Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study. J Crit Care 2001; 16 (4) 161-166
64 Lacherade JC, Cook D, Heyland D, Chrusch C, Brochard L, Brun-Buisson C ; French and Canadian ICU Directors Groups. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. J Crit Care 2003; 18 (4) 228-237
65 Robertson MS, Nichol AD, Higgins AM , et al; VTE Point Prevalence Investigators for the Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society Clinical Trials Group. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units. Crit Care Resusc 2010; 12 (1) 9-15
66 Goldhaber SZ. Venous thromboembolism in the intensive care unit: the last frontier for prophylaxis. Chest 1998; 113 (1) 5-7
67 Marsh H, Reynard J. Thromboprophylaxis for patients at high risk of VTE. Lancet 2008; 371 (9628) 1912 , author reply 1912–1913
68 Tooher R, Middleton P, Pham C , et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg 2005; 241 (3) 397-415
69 Cabana MD, Rand CS, Powe NR , et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282 (15) 1458-1465
70 Bhanji F, Mancini ME, Sinz E , et al. Part 16: education, implementation, and teams: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122 (18, Suppl 3) S920-S933
71 Rahim SA, Panju A, Pai M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res 2003; 111 (4-5) 215-219
72 McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol 2007; 7: 30
73 Bikdeli B, Piazza G . Review of Piazza et al. Coexisting heart failure in DVT patients. Ethrombosis, June 2008. Available at: http://www.natfonline.org/ethrombosis/review-of-piazza-et-al-coexisting-heart-failure-in-dvt-patients
74 Piazza G, Seddighzadeh A, Goldhaber SZ. Heart failure in patients with deep vein thrombosis. Am J Cardiol 2008; 101 (7) 1056-1059
75 Adams KF, Lindenfeld J, Arnold JMO , et al; Heart Failure Society Of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006; 12 (1) e1-e2
76 Dickstein K, Cohen-Solal A, Filippatos G , et al; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29 (19) 2388-2442
77 Jessup M, Abraham WT, Casey DE , et al, writing on behalf of the 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult Writing Committee. 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 119 (14) 1917-2016
78 Mosen D, Elliott CG, Egger MJ , et al. The effect of a computerized reminder system on the prevention of postoperative venous thromboembolism. Chest 2004; 125 (5) 1635-1641
79 Holley AB, Moores LK, Jackson JL. Provider preferences for DVT prophylaxis. Thromb Res 2006; 117 (5) 563-568
80 Golash A, Collins PW, Kynaston HG, Jenkins BJ. Venous thromboembolic prophylaxis for transurethral prostatectomy: practice among British urologists. J R Soc Med 2002; 95 (3) 130-131
81 Gnanalingham KK, Holland JP. Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients. J Clin Neurosci 2003; 10 (4) 467-469
82 Sharif KM, Rehman SF, Nunn T, Bagga TK. Implementation of the NICE guidelines for venous thromboprophylaxis; a national survey of hip surgeons. Hip Int 2009; 19 (1) 58-63
83 Ahmad HA, Geissler A, MacLellan DG. Deep venous thrombosis prophylaxis: are guidelines being followed?. ANZ J Surg 2002; 72 (5) 331-334
84 Burns PJ, Wilsom RG, Cunningham C. Venous thromboembolism prophylaxis used by consultant general surgeons in Scotland. J R Coll Surg Edinb 2001; 46 (6) 329-333
85 Ploumis A, Ponnappan RK, Bessey JT, Patel R, Vaccaro AR. Thromboprophylaxis in spinal trauma surgery: consensus among spine trauma surgeons. Spine J 2009; 9 (7) 530-536
86 Williams EV, Williams RS, Hughes JL, Williams KL, Foster ME, Lewis MH. Prevention of venous thromboembolism in Wales: results of a survey among general surgeons. Postgrad Med J 2002; 78 (916) 88-91
87 Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell Jr DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg 2010; 251 (2) 344-350
88 Barbar S, Noventa F, Rossetto V , et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost 2010; 8 (11) 2450-2457
89 Harinath G, St John PH. Use of a thromboembolic risk score to improve thromboprophylaxis in surgical patients. Ann R Coll Surg Engl 1998; 80 (5) 347-349
90 Samama MM, Dahl OE, Mismetti P , et al. An electronic tool for venous thromboembolism prevention in medical and surgical patients. Haematologica 2006; 91 (1) 64-70
91 Maynard G, Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis 2010; 29 (2) 159-166
92 Wolpin S, Lee JA, Glenny RW, Wittkowsky AK, Wolf FM, Zierler BK. Evaluation of online training on the prevention of venous thromboembolism. Vasc Endovascular Surg 2011; 45 (2) 146-156
93 Fahimi F, Baniasadi S, Behzadnia N, Varahram F, Ghazi-Tabatabaie L. Enoxaparin utilization evaluation: an observational prospective study in medical inpatients. Iran J Pharmaceut Res 2008; 7: 77-82
94 McMullin J, Cook D, Griffith L , et al. Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med 2006; 34 (3) 694-699
95 North American Thrombosis Forum: Mission, Vision and Multidisciplinary Approach. Accessible at http://www.natfonline.org/about/mission-vision-multidisciplinary-approach . Last accessed, July 22, 2011
96 Clark P, Wu O, Greer IA, Lowe GD. Venous thrombosis prevention - more than just guidelines. Br J Haematol 2010; 149 (1) 50-54
97 Goldhaber SZ, Rosenbaum E. The Surgeon General’s call to action exemplifies the role of advocacy in preventing venous thromboembolism. Am J Med 2009; 122 (9) 791-792
98 Maynard G, Stein J. Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement. Prepared by the Society of Hospital Medicine. AHRQ Publication No. 08–0075. Rockville, MD: : Agency for Healthcare Research and Quality. August 2008
99 Moll S, Mackman N. Venous thromboembolism: a need for more public awareness and research into mechanisms. Arterioscler Thromb Vasc Biol 2008; 28 (3) 367-369
100 Galanis T, Thomson L, Palladino M, Merli GJ. New oral anticoagulants. J Thromb Thrombolysis 2011; 31 (3) 310-320
101 Shachak A, Jadad AR. Electronic health records in the age of social networks and global telecommunications. JAMA 2010; 303 (5) 452-453
102 Nair BG, Newman SF, Peterson GN, Wu WY, Schwid HA. Feedback mechanisms including real-time electronic alerts to achieve near 100% timely prophylactic antibiotic administration in surgical cases. Anesth Analg 2010; 111 (5) 1293-1300
103 Cohen AT, Agnelli G, Anderson FA , et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (4) 756-764
104 Ageno W, Dentali F. Prevention of in-hospital VTE: why can’t we do better?. Lancet 2008; 371 (9610) 361-362
105 Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med 2007; 167 (14) 1471-1475
106 Bosson JL, Pouchain D, Bergmann JF ; for the ETAPE Study Group. A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices. J Intern Med 2006; 260 (2) 168-176